Plantex has entered a strategic merger with Nactarome, backed by Mérieux Equity Partners, to enhance its position in the growing nutraceutical market.
Target Information
Plantex, founded in 1990 in Saint-Michel-sur-Orge, Essonne, specializes in the nutraceutical, food, animal nutrition, and cosmetic markets. With a workforce of 80 employees, the company has significantly enhanced its production capacity and initiated sales in the United States, along with establishing a commercial office in Spain and a production site in Morocco. Its expertise in organic plant extraction has generated approximately 30 million Euros in revenue, broadening the offerings of Nactarome, which had not previously ventured into the nutraceutical and dietary supplement ingredients sector.
Industry Overview
In Italy, the nutraceutical industry is experiencing robust growth, driven by increasing consumer awareness about health and wellness. As people become more health-conscious, the demand for natural ingredients and supplements has surged, prompting companies to innovate and diversify their product lines. This sector’s expansion is supported by advancements in science and technology that enhance the effectiveness and accessibility of nutraceutical products.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The food and beverage industry in Italy is also evolving, with a rising emphasis on clean-label products and natural ingredients. This shift not only addresses the growing consumer demand for transparency but al
Similar Deals
Nactarome
invested in
Plantex
in 2022
in a Merger deal
Disclosed details
Revenue: $220M